FDA Approved: ABACAVIR AND LAMIVUDINE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approves Camber Pharmaceuticals' supplemental application for a generic abacavir/lamivudine combination product for HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ABACAVIR AND LAMIVUDINE (abacavir/lamivudine)

Snippet

SUPPL AP for ABACAVIR AND LAMIVUDINE (ABACAVIR AND LAMIVUDINE)